Shiratori Y, Tanaka M, Hai K, Kawase T, Shirna S, Sugimoto T
2nd Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
Hepatology. 1990 Feb;11(2):183-92. doi: 10.1002/hep.1840110205.
Although administration of 100 mg galactosamine caused severe hepatic injury in C3H/HeN mice, splenectomy reduced the grade of this hepatotoxicity. However, this hepatic injury was scarcely detected in the endotoxin-resistant C3H/HeJ mice. In addition, in contrast to high lethality in C3H/HeN mice with a combined administration of galactosamine and endotoxin, splenectomy rendered C3H/HeN mice slightly resistant to this treatment. Further resistance was demonstrated in C3H/HeJ mice. In an attempt to clarify the role of endotoxin-responsive spleen cells in the pathogenesis of hepatic injury, we investigated galactosamine-induced hepatic injury by transfer of lipopolysaccharide-treated C3H/HeN or C3H/HeJ spleen cells. Both oxygen-derived free radical production and the proportion of macrophages in spleen cells were markedly enhanced in C3H/HeN mice after an intraperitoneal injection of lipopolysaccharide. Further increase in oxidative free radical production was found in the dish-adherent cells (macrophages). These enhancements were not demonstrated in lipopolysaccharide-treated C3H/HeJ spleen cells. Although hepatic injury was not demonstrated in both C3H/HeN and C3H/HeJ mice treated with 35 mg galactosamine alone, severe hepatotoxicity was found in these galactosamine-treated mice when they received lipopolysaccharide-activated C3H/HeN spleen cells, especially macrophages. Simultaneous administration of superoxide dismutase with the activated spleen cells reduced the grade of hepatic injury. On the other hand, hepatic injury was not demonstrated in the galactosamine-treated C3H/HeN or C3H/HeJ mice when they received lipopolysaccharide-treated C3H/HeJ spleen cells, although 3H-galactosamine incorporation into hepatocytes was nearly identical in both C3H/HeN and C3H/HeJ mice. These results suggest that oxidative free radicals of lipopolysaccharide-responsive macrophages could contribute to the pathogenesis of galactosamine-induced hepatic injury.
虽然给C3H/HeN小鼠注射100mg半乳糖胺会导致严重肝损伤,但脾切除可减轻这种肝毒性的程度。然而,在内毒素抗性的C3H/HeJ小鼠中几乎检测不到这种肝损伤。此外,与联合给予半乳糖胺和内毒素时C3H/HeN小鼠的高致死率相反,脾切除使C3H/HeN小鼠对这种治疗稍有抗性。C3H/HeJ小鼠表现出更强的抗性。为了阐明内毒素反应性脾细胞在肝损伤发病机制中的作用,我们通过转移经脂多糖处理的C3H/HeN或C3H/HeJ脾细胞来研究半乳糖胺诱导的肝损伤。腹腔注射脂多糖后,C3H/HeN小鼠脾细胞中氧衍生自由基的产生和巨噬细胞的比例均显著增加。在贴壁细胞(巨噬细胞)中发现氧化自由基产生进一步增加。在用脂多糖处理的C3H/HeJ脾细胞中未观察到这些增强现象。虽然单独用35mg半乳糖胺处理的C3H/HeN和C3H/HeJ小鼠均未出现肝损伤,但当这些经半乳糖胺处理的小鼠接受脂多糖激活的C3H/HeN脾细胞(尤其是巨噬细胞)时,会出现严重的肝毒性。超氧化物歧化酶与激活的脾细胞同时给药可减轻肝损伤的程度。另一方面,当经半乳糖胺处理的C3H/HeN或C3H/HeJ小鼠接受经脂多糖处理的C3H/HeJ脾细胞时,未出现肝损伤,尽管C3H/HeN和C3H/HeJ小鼠肝细胞对半乳糖胺的摄取几乎相同。这些结果表明,脂多糖反应性巨噬细胞产生的氧化自由基可能参与半乳糖胺诱导的肝损伤发病机制。